U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment



Remarks by HHS Secretary Becerra at the Global COVID-19 Summit
May 12, 2022 | Speech

NIH Licenses COVID-19 Research Tools and Early-Stage Technologies to WHO Program
May 12, 2022 | News Release


BARDA-ASPR – U.S. Department of HHS [to 14 May 2022]
No new digest content identified.





Press Announcements
[No new digest content identified]

Regulatory Actions
Vaccines and Related Biological Products Advisory Committee– FDA
:: On June 7, FDA intends to convene VRBPAC to discuss an EUA request for a COVID-19 vaccine manufactured by Novavax to prevent COVID-19 in individuals 18 years of age and older.
:: On June 8, 21 and 22, the FDA has held dates for the VRBPAC to meet to discuss updates to the Moderna and Pfizer-BioNTech EUAs for their COVID-19 vaccines to include younger populations. As the sponsors complete their submissions and the FDA reviews that data and information, it will provide additional details on scheduling of the VRBPAC meetings to discuss each EUA request.
:: On June 28, the FDA plans to convene the VRBPAC to discuss whether the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified, and if so, which strain(s) should be selected for Fall 2022. This meeting is a follow-up to the April 6 VRBPAC meeting that discussed general considerations for future COVID-19 vaccine booster doses and the strain composition of COVID-19 vaccines to further meet public health needs.

…Once the meeting dates are finalized, the FDA intends to make background materials available to the public, including the meeting agenda and committee roster, no later than two business days before each meeting…





White House [U.S.] [to 14 May 2022]
Briefing Room – Selected Major COVID Announcements
[See announcements associated with the 2nd Global COVID-19 Summit above]
Remarks by President Biden at the Global COVID-⁠19 Summit
May 12, 2022 • Speeches and Remarks

2nd COVID-⁠19 Co-Host Statement
May 12, 2022 • Statements and Releases

Background Press Call by Senior Administration Official Previewing the Second Global COVID Summit
May 12, 2022 • Press Briefings

Remarks by Vice President Harris at the Global Covid-19 Summit
May 12, 2022 • Speeches and Remarks

2nd Global COVID-⁠19 Summit Commitments
May 12, 2022 • Statements and Releases

U.S. FACT SHEET: The 2nd Global COVID-⁠19 Summit:
May 12, 2022 • Statements and Releases

Statement from President Biden and President von der Leyen on occasion of the second Global COVID-⁠19 Summit, May 12, 2022
May 12, 2022 • Statements and Releases

A Proclamation on Remembering the 1,000,000 Americans Lost to COVID-⁠19
May 12, 2022 • Presidential Actions

Statement from President Joe Biden Marking One Million American Lives Lost to COVID-⁠19
May 12, 2022 • Statements and Releases


USAID [to 14 May 2022]
Selected Press Releases, Statements, Announcements
At Second Global COVID-19 Summit, USAID Announces $220 Million Commitment to Prevent Future Pandemics and Test and Treat Against COVID-19
May 12, 2022
Today, at the second Global COVID-19 Summit, the United States Agency for International Development (USAID) announced new efforts to prevent future pandemics and pilot a lifesaving test and treat strategy, as part of USAID’s ongoing leadership to end the acute phase of the COVID-19 pandemic and advance global health security.

The United States Provides Nearly $808 Million in Emergency Humanitarian Assistance for Syria
May 10, 2022
Today, U.S. Ambassador to the United Nations Linda Thomas-Greenfield announced the United States is providing nearly $808 million in additional humanitarian assistance for the Syria crisis response at the sixth Brussels Conference on “Supporting the Future of Syria and the Region,” hosted by the European Union. This new funding includes nearly $446 million from the U.S. Agency for International Development (USAID) and is the largest USAID funding contribution for Syria this year.